Your browser doesn't support javascript.
loading
Effect of rosuvastatin 20 mg versus rosuvastatin 5 mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial.
Cha, Jung-Joon; Hong, Soon Jun; Kim, Ju Hyeon; Lim, Subin; Joo, Hyung Joon; Park, Jae Hyoung; Yu, Cheol Woong; Lee, Pil Hyung; Lee, Seung Whan; Lee, Cheol Whan; Moon, Jae Youn; Lee, Jong-Young; Kim, Jung-Sun; Park, Jae Suk; Lee, Kyounghoon; Lim, Sang Yup; Na, Jin Oh; Cho, Jin-Man; Kim, Seok Yeon; Lim, Do-Sun.
Afiliação
  • Cha JJ; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Hong SJ; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea. Electronic address: psyche94@gmail.com.
  • Kim JH; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Lim S; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Joo HJ; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Park JH; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Yu CW; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Lee PH; Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lee SW; Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lee CW; Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Moon JY; Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
  • Lee JY; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim JS; Division of Cardiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Park JS; Division of Cardiology, Incheon Sejong Hospital, Incheon, Republic of Korea.
  • Lee K; Division of Cardiology, Gachon University of Medicine and Science, Gil Medical Centre, Incheon, Republic of Korea.
  • Lim SY; Division of Cardiology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Na JO; Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Cho JM; Department of Cardiovascular Medicine, Kyung Hee University, Seoul, Republic of Korea.
  • Kim SY; Division of Cardiology, Seoul Medical Center, Seoul, Republic of Korea.
  • Lim DS; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Am Heart J ; 261: 45-50, 2023 07.
Article em En | MEDLINE | ID: mdl-36934981
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Humans Idioma: En Revista: Am Heart J Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Humans Idioma: En Revista: Am Heart J Ano de publicação: 2023 Tipo de documento: Article